Fazal Malik August 2016

Ot
AC
PPO: FAZLE MALIK
Products
Jul-05
Month's Sales
Month
L/Y
TGT
Sale
% Ach.
G%
Est.
Ringolact
3562
956
938
98
-74
Ringolact D
3505
939
800
85
-77
38
-100
1933
1738
90
-81
140
125
89
-40
160
18
33
-54
30
111
100
90
28
120
44
33
75
32
40
Plabolyte M 2183
Brands
9250
Pletaal 50mg 208

Pletaal 100mg 13
Aminoleban
78
Aminoleban Oral 25
Pan Amin G
360
287
294
102
-18
Aminovel
667
766
903
118
35
1000
Proten
116
287
100
35
-14
378
Revenue
921886
625433
608278
97
-34
556942
Otsuka Pakistan Limited

ACHIEVEMENT FEB 2014
YTD Sales
L/Y
TGT
Sale
% Ach.
10399
2879
2170
8894
2687
1697
4847
943
648
24140
6509
4515
443
413
376
47
63
23
250
326
320
80
117
84
1006
680
655
1631
1993
2000
237
681
439
2595476
1759506
1509163
75
63
69
207
91
37
98
72
96
100
64
86
Revenue
Cont. % in
Revenue
-79
-81
-87
-81
-15
-51
28
5
-35
23
85
123148
96305
38005
257457
208763
21044
138880
151990
117808
586500
26656
8
6
3
17
14
1
9
10
8
39
2
-42
1509098
100
G%
Product: RINGOLACT
Fazle Malik/Psh/JAN2014
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Efforts
High
Saima Gilani
GIFTASUP
150
180
120
210
250
260
200
Abida Nasreen
GIFTASUP
110
130
115
150
180
155
220
Amin Jan Gandapor
WHO
180
190
160
210
220
200
230
Irshad Ahmed
WHO
220
110
140
130
170
210
200
Sabir Khan
WHO
80
170
210
150
200
175
230
Zia Mohammad
WHO
90
70
120
210
160
160
190
Roohul Muqim
GIFTASUP
200
180
150
170
220
210
190
Tariq Saeed
GIFTASUP
220
180
120
140
200
165
210
Qutbe Alam
GIFTASUP
110
100
140
210
200
180
160
10
Younas Khan
GIFTASUP
190
120
210
200
180
220
90
High
High
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
Strategy
M.Kashif
WHO/GIFTASUO
60
120
120
220
110
110
Ilyas
WHO/GIFTASUO
20
25
20
20
20
25
30
Jamil Ahmed
WHO/GIFTASUO
10
30
20
25
10
20
50
Saeeda Majeed
WHO/GIFTASUO
25
21
25
18
12
20
40
Fazia Raza
WHO/GIFTASUO
30
35
30
25
25
30
35
Efforts
Product: PLABOLYT-M
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Efforts
High
Amin Jan Gandapor
NELSON TEXT BOOK
80
100
120
80
100
120
150
High
Irshad Ahmed
NELSON TEXT BOOK
150
100
110
110
120
120
150
High
Sabir Khan
NELSON TEXT BOOK
120
130
130
100
120
150
150
High
Zia Mohammad
NELSON TEXT BOOK
140
120
120
80
90
100
150
Mohammad Ilyas
NELSON TEXT BOOK
90
150
140
100
100
150
200
Anwarzeb Jan
NELSON TEXT BOOK
110
200
200
150
120
180
250
Samreen Ahmed
NELSON TEXT BOOK
120
80
90
70
120
110
125
Ataur Rahman
GIFTASUP
80
110
190
200
100
90
130
High
Mohammad Naeem Khattak
GIFTASUP
90
110
75
85
70
65
140
Hogh
Younas Khan
GIFTASUP
120
125
180
150
100
90
210
10
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
Strategy
Arifullah
WHO
20
30
30
35
15
20
40
Mohammad Iqbal
WHO
20
25
30
35
25
20
45
Umar Ali
WHO
25
30
30
30
30
25
30
Jamil Ahmed
WHO
30
40
25
25
30
30
40
Saima Gilani
GIFTASUP
12
20
40
35
30
35
45
Efforts
High
Product: AMINOLEBAN
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Efforts
High
Humayoun
Fischers' Ratio/CLD
24
24
30
25
20
24
25
Hasimud-Din
Fischers' Ratio/CLD
16
12
15
12
20
22
20
High
Jamalud-Din
Fischers' Ratio/CLD
14
14
12
12
12
10
15
High
Wazir Mohammad
Fischers' Ratio/CLD
12
14
15
16
10
14
High
Iqbal Haider
Fischers' Ratio/CLD
30
35
30
18
14
11
16
High
Baghdad Khan
Fischers' Ratio/CLD
25
20
20
16
15
10
20
High
M.Naveed Anwar
Fischers' Ratio/CLD
Zahid Khattak
Fischers' Ratio/CLD
12
12
12
14
10
Shafqatur Rehman
NH3 detoxification through Kreb's Cycle/CLD
16
14
12
10
10
12
Humaira Khan
Fischers' Ratio/CLD
10
High
High
10
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
Strategy
Salim Iqbal
Fischers' Ratio/CLD
Fariduulah Shah
Fischers' Ratio/CLD
10
Tariq Abdul Aziz
Fischers' Ratio/CLD
Mohammad Abbass
Fischers' Ratio/CLD
Humera Achakzai
Fischers' Ratio/CLD
High
Efforts
Product: AMINOVIL-600
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Ataur Rahman
PRE & POST OP
22
18
16
12
25
20
16
Mohammad Naeem Khattak
PRE & POST OP
20
22
24
16
15
18
20
Mohammad Iqbal
Prevention and treatment Cachexia
25
25
16
20
20
25
18
Rawail Ahmed
16
15
20
16
22
16
20
Shaheen Iqbal
23
20
15
20
15
23
15
Mohammad Rauf Khattak
20
25
25
35
35
22
25
Nabila Javed
25
30
30
20
30
30
30
Abdul Wahid
100
110
90
80
76
75
90
Abbass Ilyas
15
16
20
16
22
16
12
10
Yaqub Mahmudi
20
14
10
15
20
15
10
New Focus (only 5)
Strategy
Last 6 months Sales

1
Current
Month's
Sales
Zainab Jan
10
10
Humera Khan
Old Age and COPD
10
Jamil Ahmed
Post-op
10
12
12
Zafar Iqbal
Old Age and COPD
12
Wazir Mohammad
Old Age and COPD
Efforts
High
Efforts
High
Fazle Malik/Psh/JAN2014
Efforts
Medium
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Efforts
Medium
Low
Low
Low
Low
Low
Efforts
Medium
Low
Low
Low
Low
Low
Low
Efforts
Medium
Low
Low
Low
Low
Low
Low
Efforts
Medium
Low
Low
Low
Medium
Low
Low
Efforts
Medium
LOW
LOW
LOW
LOW
LOW
Efforts
Medium
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Low
Efforts
Medium
Low
Low
Low
Low
Low
Low
Product: RINGOLACT-D
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Mohammad Riaz
Acid/Base Balance
190
130
110
120
180
210
230
Mumtaz
Acid/Base Balance
90
120
150
100
160
110
130
Mohammad Ali
Acid/Base Balance
180
120
150
120
160
200
210
Bahadur Zaman
Acid/Base Balance
220
150
200
150
220
230
200
Shir Mohammad
Acid/Base Balance
110
120
200
150
170
190
300
Safia Misbah
Acid/Base Balance
130
100
120
110
200
210
210
Shabir Ahmed
WHO Recommendations
100
85
90
150
125
120
230
Syed Alam
WHO Recommendations
110
220
210
120
110
130
215
Omar Salim
WHO Recommendations
130
120
110
120
90
160
210
Mussarat Begam
WHO Recommendations
120
150
80
90
110
100
200
10
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
Strategy
Altaf Khan
WHO Recommendations
25
20
10
15
20
25
Shakir Khan
WHO Recommendations
20
20
12
15
15
25
30
Sardar Hussain
WHO Recommendations
35
30
10
15
15
30
40
Rukhsana
Acid/Base Balance
20
15
15
20
20
25
30
Razia Sultana
GIFTASUP
10
25
20
10
25
12
25
FAZLE MALIK/Psh/Oct2013
Product: PANAMIN-G
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Saima Gilani
Low Birth Wieght
20
30
25
15
15
22
25
Abida Nasreen
Low Birth Wieght
24
18
20
20
20
18
22
Naila Bukhari
Low Birth Wieght
25
16
22
16
18
25
20
Sharin Fatima
Low Birth Wieght
22
15
24
18
16
27
18
Shandana
Low Birth Wieght
18
20
28
22
20
28
30
Saeeda Majeed
Low Birth Wieght
15
21
16
21
20
20
25
Nargus Mushtaq
Low Birth Wieght
25
22
17
20
20
25
15
Marayam Asad
Low Birth Wieght
20
20
24
15
25
20
18
Nabila Javed
Ca Patients
22
15
25
25
15
30
24
10
Afsha Shafiq
Low Birth Wieght
16
20
20
17
18
15
25
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
10
Strategy
Palwasha Ali
Low Birth Wieght
Fazia Raza
Low Birth Wieght
Safia Misbah
Low Birth Wieght
Saeed Khan
Malnutrition
Sara Ali
Low Birth Wieght
Product: PLETAAL
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Strategy
Miqdad Ali Khan
Triple Antiplatlet therapy Intrvntion
Momin Salahud-Din
Karamat Ali Shah
Momin Khan
Humayoun Khan
PAD
Faizur Rahman
PAD
Hashimud-Din
PAD
Baghdad Khan
PAD
Ataur Rahman
DFU
M. Naeem Khattak
DFU
10
Last 6 months Sales

New Focus (only 5)
Current
Month's
Sales
Strategy
Mohammad Subhan
ICAS
Sohail Khan
ICAS
Mushtaq Ahmed
ICAS
Shuib Khan Dawar
TAT in Intervention
Mohammad Zarin
DFU
Product:
Last 6 months Sales

Top Ten Customers
Current
Month's
Sales
Current
Month's
Sales
Strategy
1
1
2
3
4
5
6
7
8
9
10
Last 6 months Sales

New Focus (only 5)
Strategy
1
1
2
3
4
5
Efforts
High
Medium
Low
Medium
Medium
Medium
Medium
Medium
Low
Low
Low
Low
Low
Efforts
High
Medium
Low
Low
Low
Low
Low
Low
Efforts
High
Medium
Low
Low
Low
Low
Low
Low
LOW
Low
Low
Low
Low
Efforts
High
Medium
Low
Low
Low
Low
Low
Low
Efforts
High
Medium
Low
Low
Low
Low
Low
High
High
High
High
High
High
Low
Efforts
High
Medium
Low
Medium
Low
Low
High
Low
Medium
Efforts
High
Medium
Low
Efforts
High
Medium
Low
Brick Rev.Potential / M
Total
OPL
PRODUCTS
P 50mg
P100mg
Ringt
Ringt D
PM
Brands
PAG
AMV
INJ
ORAL
Proten
12L
243556.62
A
2
DOCTORS
SELTD
CONVRTD
12
12
63
56
50
169
12
38
13
13
32
TOTAL REVENUE
5
6
33
30
30
93
7
13
7
5
10
B
38
Doctors
C
24
AVG/SALE/M
L/Y
CURNT
7
2
450
230
1230
1910
62
70
35
9
130
187930
REVENUE/DR/MONTH
6
2
802
383
1709
2894
45
66
37
8
201
243557
3806
Brief of Activities Done in this brick
FM REVIEW
Total
64
JAN
7
2
790
450
900
2140
64
40
51
8
320
209007
3266
POS
Total
Popu.
1m
FEB
8
3
660
440
1600
2700
17
47
33
11
212
228226
3566
%Age Cont.vs PPO Total
Chemist
50
Time spent
24%
Revn.
41%
MAR
APR
MAY
4
2
780
390
1800
2970
46
54
36
8
230
244933
3827
WP
5
1
670
500
2250
3420
35
93
45
9
240
286956
4484
WP
6
1
1270
322
1670
3262
42
76
40
10
180
269374
4209
JUN
4
2
650
239
1980
2869
60
45
32
7
110
228303
3567
OTSUKA PAKISTAN LIMITED

BRICK WISE ANALYSIS
Total
OPL
700000
160000
A
14
DOCTORS
SELTD
CONVRTD
P 50mg
14
4
P100mg
10
0
Ringt
21
9
Ringt D
21
5
PM
21
11
Brands
63
25
PAG
3
0
AMV
16
7
INJ
7
1
ORAL
7
1
Proten
0
0
TOTAL REVENUE
B
15
Doctors
C
0
AVG/SALE/M
L/Y
CURNT
22
16
0
0
754
124
823
120
615
660
2192
904
0
0
120
60
10
20
0
4
0
0
178873.04
95903.88
8131
4359
REVENUE/DR/MONTH
PRODUCTS
FM REVIEW
Total
29
JAN
12
0
200
120
1200
1520
0
180
47
0
0
187487
8522
Total
Popu.
150000
FEB
14
0
0
0
500
500
0
160
0
10
0
102112.08
4641
Chemist
1
Time spent
16%
Revn.
18%
MAR
APR
MAY
26
0
300
180
1000
1480
0
180
20
12
0
183845.52
8357
19
0
120
120
600
840
0
230
20
0
0
135714.68
6169
20
0
220
0
1000
1220
0
220
20
10
0
173528.4
7888
JUN
24
0
120
160
700
980
0
150
20
10
0
141335.78
6424

BRICK WISE ANALYSIS
Total
400000
OPL
150000
PRODUCTS
P 50mg
P100mg
Ringt
Ringt D
PM
Brands
PAG
AMV
INJ
ORAL
Proten
A
8
DOCTORS
SELTD
CONVRTD
7
4
7
2
12
9
12
6
7
6
31
21
5
4
15
9
12
5
12
5
6
0
TOTAL REVENUE
B
19
Doctors
C
7
AVG/SALE/M
L/Y
CURNT
7
6
3
2
259
2282
277
1353
156
1015
692
4650
284
279
229
211
28
27
13
14
20
20
201848.15
423868.59
5937
12467
REVENUE/DR/MONTH
Total
34
JAN
12
4
4500
3600
1200
9300
66
72
26
13
0
615008.36
18088
Total
Popu.
200000
FEB
12
3
1600
1550
800
3950
43
66
25
9
10
292865.24
8614
Chemist
15
Time spent
24%
Revn.
52%
MAR
APR
MAY
15
2
2200
650
800
3650
60
45
32
12
12
280367.97
8246
3
0
1450
760
760
2970
710
492
39
7
12
475401.2
13982
10
1
2818
1702
1367
5887
445
349
30
14
49
570094.32
16767
JUN
6
2
825
595
973
2393
231
193
10
14
37
274006.3
8059
FM REVIEW

BRICK WISE ANALYSIS
Total
OPL
PRODUCTS
P 50mg
P100mg
Ringt
Ringt D
PM
Brands
PAG
AMV
INJ
ORAL
Proten
400000
120000
A
0
DOCTORS
SELTD
CONVRTD
2
2
27
27
27
B
22
Doctors
C
17
AVG/SALE/M
L/Y
CURNT
12
12
12
0
0
910
910
707
1
1
965
1551
622
81
36
2527
3138
7
4
2
2
12
3
2
0
0
1
22
0
0
0
13
34
36
0
0
32
Total
39
Total
Popu.
2L
Chemist
22
Time spent
12%
Revn.
41%
JAN
FEB
MAR
APR
MAY
JUN
900
608
850
1345
1050
1500
630
2400
1960
2050
1560
1280
440
1970
722
3730
340
3150
1392
4787
660
3270
412
3192
27
24
23
42
39
56
37
22
30
42
52
40
21
42
42
21
42
21
TOTAL REVENUE
151225.83
202764.468
134986.11
230927.68
199172.24
299903.01
215159.5
207993.3
5199.0889231 3461.1823077 5921.2225641 5106.9805128 7689.8207692 5516.9102564 5333.1615385
REVENUE/DR/MONTH
FM REVIEW
JUL
6
2
680
120
1765
2565
81
104
39
10
112
241194
3769
AUG
4
1
340
180
1600
2120
68
140
26
6
320
221684
3464
SEP
0
0
ITED
SIS
JUL
O
0
0
0
720
720
0
O
0
0
0
#VALUE!
#VALUE!
AUG
3
0
0
0
320
320
0
120
0
0
0
55623.66
2528
SEP
0
0
MITED
SIS
JUL
5
2
767
110
451
1328
187
153
26
9
10
187712.75
5521
AUG
6
0
770
130
450
1350
110
330
12
5
4
212100.8
6238
SEP
0
0
0
0
ITED
SIS
ITED
JUL
AUG
SEP
499
350
750
500
532
1781
512
1362
0
0
52
48
30
30
36
42
124398.91
99752.54
3189.7156 2557.7574359
0
0
0
PPO Name:
Fazle Malik
Brick/Are
KTH+U/Road
OCT
NOV
DEC
0
0
TOTAL
0
0
0
0
44
14
5840
2641
13565
22046
413
599
302
69
1724
1929678
30151
1938
59
86
43
10
246
246
PPO Name:
Fazle Malik
Brick / Area:
RMI
OCT
NOV
DEC
0
0
TOTAL
0
0
0
0
118
0
960
580
6040
7580
0
1240
127
42
0
1003001.76
45591
17
0
137
83
863
0
177
18
6
0
PPO Name:
Fazle Malik
Brick / Area:
Dabgari+W/Sale
OCT
NOV
DEC
0
0
TOTAL
0
0
0
0
69
14
14930
9097
6801
30828
1852
1700
200
83
134
2907556.94
85516
PPO Name:
Fazle Malik
Brick / Area:
Harichand+Omarzai
2133
1300
972
265
4404
243
29
12
19
OCT
NOV
DEC
TOTAL
1015
7102
1590
11130
716
0
0
0
0
0
0
5010
23242
44
3320
311
40
283
38
0
0
0
0
0
0
0
0
267
1512293.29
PPO Name:FAZ
Product: Brands
Brick Name
January
February
March
April
May
June
July
August
September
October
November
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
KTH
392
2140
1258
2970
2854
3420
4664
3262
5725
2296
4900
2869
4910
2565
5475
2660
5054
701
3631
600
1840
HARICHAND
105
1000
597
2250
1355
2130
2214
3250
2717
1640
2326
1960
2331
1000
2598
900
2399
300
1723
201
808
OMARZAI
105
970
487
1480
11O4
1020
1804
1537
2214
1630
1895
1232
1899
781
2117
1000
1954
316
1404
196
711
RMI
320
1520
841
500
1908
1480
3119
840
3828
1220
3277
980
3283
720
3660
210
3380
80
2428
330
1230
W/S if any
177
9300
284
3950
645
3650
1054
2970
1293
5887
1107
2393
1108
1328
1236
6082
1142
1004
822
1501
416
5
6
7
8
9
10
TOTAL UNIT
TOTAL REVENUE
1099 14930 3467 11150 6762 11700 12855 11859 15777 12673 13505 9434 13531 6394 15086 10852 13929 2401 10008 2828
63
857
199
Hihglight Brick where activity was done
Activity in Month
Detail
When/Where
640
388
671
738
681
905
727
775
541
777
367
866
623
799
138
574
162
5005
287
Product: Aminoleban Inj

Brick Name
January
February
March
April
May
June
July
August
September
October
November
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2015
2015
2016
2012
2013
2012
2013
2012
KTH
51
51
20
33
37
36
45
34
40
39
32
42
39
31
26
35
20
51
31
40
HARICHAND
OMARZAI
RMI
30
47
10
15
20
20
12
20
20
20
55
10
12
17
30
14
W/S if any
41
35
25
53
29
58
12
48
33
12
64
24
45
28
22
42
33
32
TOTAL UNIT
122
133
55
86
81
114
77
94
93
47
64
127
47
110
81
75
42
110
94
86
TOTAL REVENUE
53
58
24
37
35
49
33
41
40
20
28
55
20
48
35
33
18
48
41
37
5
6
7
8
9
10
Activity in Month
Detail
When/Where
Product:
Brick Name
Pletaal 50mg
January
February
March
April
May
June
July
August
September
October
November
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2013
2014
2012
2013
2012
2013
2012
KTH
12
22
12
24
17
14
11
HARICHAND
OMARZAI
11
RMI
27
12
24
14
22
26
10
19
18
20
28
24
10
75
47
42
70
100
83
W/S if any
12
12
15
10
12
44
25
11
11
13
TOTAL UNIT
36
31
33
37
208
45
24
29
30
37
38
46
24
11
99
72
67
92
98
125
107
TOTAL REVENUE
20
17
18
21
115
25
13
16
17
21
21
26
13
55
40
37
51
54
69
59
5
6
7
8
9
10
Activity in Month
Detail
When/Where
Product: Aminovel
Brick Name
January
February
March
April
May
June
July
August
September
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2013
2014
2013
2014
October
2013
2014
November
2013
KTH
71
40
119
47
148
93
32
76
91
45
108
20
74
104
132
72
60
34
HARICHAND
25
15
15
39
30
13
30
20
12
15
20
12
22
OMARZAI
12
15
40
12
22
10
15
10
15
12
14
10
18
RMI
60
180
94
160
117
180
100
230
100
220
110
160
100
170
105
120
W/S if any
262
72
323
66
402
45
490
492
299
349
278
193
856
153
538
298
620
272
TOTAL UNIT
398
329
536
295
667
348
701
840
512
666
514
408
1052
287
860
509
702
466
TOTAL REVENUE
117
96
157
206
137
5
6
7
8
9
10
Activity in Month
Detail
When/Where
196
206
150
151
308
252
PPO Name:FAZLE MALIK

November
2016
December
2015
2016
TOTAL
2015
2016
2347
43050 23483
1114
20287 14631
907
###
10162
1570
28844
7880
9815
38065
531
0
6469
###
94221
371
###
5407
Total
November
2013
December
2012
2013
TOTAL
2012
2013
34
418
353
11
196
167
369
311
28
0
73
984
831
32
427
361
Total
November
2013
December
2012
2013
TOTAL
2012
2013
13
98
101
15
108
522
257
106
143
18
0
139
731
525
77
406
291
Total
November
2014
December
2013
2014
TOTAL
2012
2013
869
497
117
170
111
112
971
1235
4340
1668
6408
3682
1879
1080
Total
Product: PAG
Brick Name
January
February
March
April
May
June
July
August
September
October
2015
2016
2015
2016
2015
1016
2015
2016
2015
2016
2015
2016
2015
2016
2012
2013
2012
2013
2012
2013
KTH
92
66
74
17
76
46
91
35
166
42
242
60
263
81
270
117
285
120
168
111
HARCHAND
14
17
24
184
15
24
24
30
30
17
39
OMARZAI
20
15
240
18
26
22
15
41
RMI
W/S if any
234
116
276
43
284
92
445
710
650
445
906
231
988
187
1015
670
1072
225
632
192
TOTAL UNIT
326
216
350
92
360
162
960
768
846
529
1148
347
1251
320
1285
811
1357
369
800
383
TOTAL REVENUE
59
39
63
17
65
29
173
138
152
95
206
62
225
58
231
146
244
66
144
69
5
6
7
8
9
10
Activity in Month
Detail
When/Where
Product:
Brick Name
January
Aminoleban oral
February
March
April
May
June
July
August
September
October
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2013
2014
2012
2013
2012
2013
KTH
11
11
10
10
10
10
12
13
10
HARICHAND
OMARZAI
RMI
10
12
10
10
10
18
11
45
W/S if any
15
13
14
12
22
16
14
23
14
20
16
15
18
14
14
10
TOTAL UNIT
26
21
20
30
28
32
36
18
32
34
42
32
26
19
44
27
42
63
32
22
TOTAL REVENUE
47
38
36
54
51
58
65
33
58
62
76
58
47
34
80
49
76
114
58
40
5
6
7
8
9
10
Activity in Month
Detail
When/Where
Product:
Brick Name
January
Pletaal 100mg
February
March
April
May
June
July
August
September
October
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2015
2016
2013
2014
2012
2013
2012
2013
KTH
HARCHAND
OMARZAI
RMI
W/S if any
12
11
TOTAL UNIT
15
22
15
16
12
TOTAL REVENUE
14
20
14
15
11
5
6
7
8
9
10
Activity in Month
Detail
When/Where
Brick Name
1
LRH
NOWSHERA
JAHANGIRA
January
February
March
April
May
June
July
August
September
October
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
2012
2013
4
5
6
7
8
9
10
W/S if any
TOTAL UNIT
TOTAL REVENUE
Activity in Month
Detail
When/Where
November
2012
2013
December
2012
2013
TOTAL
2012
2013
90
80
1897
695
208
219
246
172
7139
2911
337
300
427
380
9490
3997
77
68
1707
719
Total
November
2012
2013
December
2012
2013
TOTAL
2012
2013
12
11
115
85
10
84
91
198
117
17
15
39
35
402
298
71
63
727
539
Total
November
2012
2013
December
2012
2013
TOTAL
2012
2013
39
35
57
35
15
15
98
78
14
14
90
71
Total
November
December
TOTAL
2012
2013
2012
2013
2012
2013
Total
PPO:FAZLE MALIK
Products
RINGOLACT
RINGOLACT-D
PLABOLYTE-M
Brands Total
Generics
Total IVS
100 ml
Pan Amin G
Aminovel
Aminoleban
Amlb. Oral
Pletaal 50mg
Pletaal 100mg
Proten
IV Revenue
CN Revenue
Total Revenue
DATE:AUGUST16
Last year
4250
1770
1595
7615
6163
13778
1081
160
560
68
26
81
12
177
846889
607302
1454191
Month's Sales
Sale
% Ach.
Target
6066
1946
32
3129
961
31
3278
3470
106
12473
6377
51
8452
6996
83
20925
13372
64
3328
3321
100
564
320
57
697
287
41
97
65
67
38
19
50
27
12
44
3
4
133
228
158
69
1397869
933162
67
684814
344541
50
2082683
1277703
61
G%
-54
-46
118
-16
14
-3
207
100
-49
-4
-27
-85
-67
-11
10
-43
-12
Last year
44308
22095
20149
86552
63499
150051
20882
3636
4239
617
219
727
72
1360
9797439
YTD Sales
Target
40611
20949
21943
83503
56917
140420
26192
3515
4366
731
289
233
36
1685
9581316
5594497
4682597
15391936
14263913
ATE:AUGUST16
YTD Sales
Sale
18690
19359
22369
60418
46501
106919
23370
1728
3424
550
208
202
29
1773
7480859
3387833
10868692
% Ach.
46
92
102
72
82
76
89
49
78
75
72
87
81
105
78
72
76
G%
-58
-12
11
-30
-27
-29
12
-52
-19
-11
-5
-72
-60
30
-24
-39
-29
YTD
Revenue
Revenue % Cont.
1177470
11
1335771
12
1543461
14
4056702
37
2185547
20
6242249
57
1238610
11
509760
5
1448352
13
276100
3
497952
5
429856
4
101703
1
124110
1
7480859
69
3387833
31
10868692
100
3
0
2818
1702
1367
445
349
30
14
49
10
1
825
595
973
231
193
10
14
37
0
0
1524
197
755
213
110
4
17
13
5
2
1057
415
451
187
153
26
9
10

Fazal Malik August 2016

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Fazal Malik August 2016

Uploaded by

Copyright:

Available Formats

Ot

Pletaal 50mg 208

Otsuka Pakistan Limited

Last 6 months Sales

Amin Jan Gandapor

Last 6 months Sales

Last 6 months Sales

Amin Jan Gandapor

NELSON TEXT BOOK

NELSON TEXT BOOK

NELSON TEXT BOOK

NELSON TEXT BOOK

NELSON TEXT BOOK

NELSON TEXT BOOK

NELSON TEXT BOOK

Mohammad Naeem Khattak

Last 6 months Sales

Last 6 months Sales

NH3 detoxification through Kreb's Cycle/CLD

Last 6 months Sales

Tariq Abdul Aziz

Last 6 months Sales

PRE & POST OP

Mohammad Naeem Khattak

PRE & POST OP

Prevention and treatment Cachexia

Prevention and treatment Cachexia

Prevention and treatment Cachexia

Mohammad Rauf Khattak

Prevention and treatment Cachexia

Prevention and treatment Cachexia

Prevention and treatment Cachexia

Prevention and treatment Cachexia

Prevention and treatment Cachexia

New Focus (only 5)

Last 6 months Sales

Prevention and treatment Cachexia

Old Age and COPD

Old Age and COPD

Old Age and COPD

Last 6 months Sales

Last 6 months Sales

Last 6 months Sales

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Last 6 months Sales

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Low Birth Wieght

Last 6 months Sales

Miqdad Ali Khan

Triple Antiplatlet therapy Intrvntion

Triple Antiplatlet therapy Intrvntion

Karamat Ali Shah

Triple Antiplatlet therapy Intrvntion

Triple Antiplatlet therapy Intrvntion